Ospemifene

Catalog No.S4285

Ospemifene Chemical Structure

Molecular Weight(MW): 378.89

Ospemifene is a non-hormonal selective estrogen receptor modulator (SERM), used for the treatment of dyspareunia.

Size Price Stock Quantity  
USD 97 In stock
USD 247 In stock

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective Estrogen/progestogen Receptor Inhibitors

Click to view more

Notes:

2. For more details, such as half maximal inhibitory concentrations (IC50s) and working concentrations of each inhibitor, please click on the link of the inhibitor of interest.
3. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
4. Orange "√" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

Biological Activity

Description Ospemifene is a non-hormonal selective estrogen receptor modulator (SERM), used for the treatment of dyspareunia.
Targets
Estrogen receptor [1]

Protocol

Solubility (25°C)

In vitro DMSO 75 mg/mL (197.94 mM)
Ethanol 71 mg/mL warmed (187.38 mM)
Water <1 mg/mL
In vivo

* 1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 378.89
Formula

C24H23ClO2

CAS No. 128607-22-7
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02638337 Recruiting Vaginal Dryness Shionogi|Shionogi Inc. December 2015 Phase 3
NCT02784613 Recruiting Vulvovaginal Atrophy|Dyspareunia Sue Goldstein|San Diego Sexual Medicine July 2015 Phase 4
NCT00729469 Completed Atrophy|Vaginal Diseases Shionogi|Hormos Medical|QuatRx Pharmaceuticals|Shionogi Inc. July 2008 Phase 3
NCT00566982 Completed Atrophy|Vaginal Diseases Shionogi|Hormos Medical|QuatRx Pharmaceuticals|Shionogi Inc. October 2007 Phase 3
NCT00630539 Completed Atrophy|Vaginal Diseases Shionogi|Hormos Medical|QuatRx Pharmaceuticals|Shionogi Inc. August 2007 Phase 2
NCT01585558 Completed Atrophy|Vaginal Diseases Shionogi|QuatRx Pharmaceuticals|Shionogi Inc. May 2006 Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Estrogen/progestogen Receptor Signaling Pathway Map

Related Estrogen/progestogen Receptor Products

Tags: buy Ospemifene | Ospemifene ic50 | Ospemifene price | Ospemifene cost | Ospemifene solubility dmso | Ospemifene purchase | Ospemifene manufacturer | Ospemifene research buy | Ospemifene order | Ospemifene mouse | Ospemifene chemical structure | Ospemifene mw | Ospemifene molecular weight | Ospemifene datasheet | Ospemifene supplier | Ospemifene in vitro | Ospemifene cell line | Ospemifene concentration | Ospemifene nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID